reports
EQS-News: Mayr-Melnhof Karton AG: MM reports first quarter 2024 result...
EQS-News: Mayr-Melnhof Karton AG / Key word(s): Quarter Results Mayr-Melnhof Karton AG: MM reports first quarter 2024 results 23.04.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Result below previous year as expected Significant volume growth at MM Board & Paper Continuity at a good level at MM Packaging Weak consumption continues to weigh on end markets Pressure on margins carries on Successful profit & cash protection programme will be continued Sales price development decisive for earnings situation in 2024 Group Key...
EQS-News: Mayr-Melnhof Karton AG: MM veröffentlicht Ergebnisse zum 1. ...
EQS-News: Mayr-Melnhof Karton AG / Schlagwort(e): Quartalsergebnis Mayr-Melnhof Karton AG: MM veröffentlicht Ergebnisse zum 1. Quartal 2024 23.04.2024 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Ergebnis erwartungsgemäß unter Vorjahr Deutlicher Mengenzuwachs bei MM Board & Paper Kontinuität auf gutem Niveau bei MM Packaging Konsumschwäche belastet weiterhin Endmärkte Margendruck hält an Erfolgreiches Profit & Cash Protection-Programm wird fortgesetzt Verkaufspreisentwicklung für Ergebnissituation 2024 entscheidend Ke...
- ABGSC Capital Goods Research
- Anders Idborg
- Karl Bokvist
- Olof Cederholm
EQS-News: OHB SE: Konzernabschluss 2023
EQS-News: OHB SE / Schlagwort(e): Jahresergebnis OHB SE: Konzernabschluss 2023 23.04.2024 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. OHB SE: Konzernabschluss 2023 Gesamtleistung erreicht EUR 1.183 Mio. Dividendenvorschlag beträgt EUR 0,60 Freiwilliges öffentliches Übernahmeangebot schreitet planmäßig voran Der OHB-Konzern (ISIN: DE0005936124, Prime Standard) erreichte im Geschäftsjahr 2023 eine Gesamtleistung von EUR 1.182,8 Mio. (Vorjahr: EUR 1.001,3 Mio.), der Umsatz veränderte sich auf EUR 1.047,8 Mio. (Vorjahr: EUR...
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc (CRN) Cairn Homes Plc: Transaction in Own Shares 23-Apr-2024 / 07:00 GMT/BST 23 April 2024 Cairn Homes plc (the “Company”) Transaction in own shares The Company announces that on 22nd of April 2024 it purchased a total of 95,711 of its ordinary shares of EUR 0.001 each (the "ordinary shares") on Euronext Dublin and the London Stock Exchange through the Company's broker Goodbody Stockbrokers UC (“Goodbody”), as detailed below. The repurchased shares will be cancelled. Euronext Dublin London Stock Exchange Number o...
EQS-News: OHB SE: Consolidated financial statements 2023
EQS-News: OHB SE / Key word(s): Annual Results OHB SE: Consolidated financial statements 2023 23.04.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. OHB SE: Consolidated financial statements 2023 Total revenues reach EUR 1,183 million Dividend recommendation amounts to EUR 0.60 Voluntary public takeover offer progressing according to plan In fiscal year 2023, the OHB Group (ISIN: DE0005936124, Prime Standard) generated total revenues of EUR 1,182.8 (previous year: EUR 1,001.3 million), while sales changed to EUR 1,047.8 milli...
Full year trading update and notice of results
Molten Ventures Plc (GROW; GRW) Full year trading update and notice of results 23-Apr-2024 / 07:00 GMT/BST 23 April 2024 Molten Ventures plc ("Molten Ventures", "Molten", or the “Group”) Full year trading update and notice of results Stable and enhanced platform, in an improving market with greater expectation for realisations Molten Ventures (LSE: GROW, Euronext Dublin: GRW), a leading venture capital firm investing in and developing high-growth digital technology businesses, today announces an update on its portfolio, NAV (unaudited) and highlights for the year ...
EQS-News: DEFENCE’S ACCUTOX ANTI-CANCER ARM-002 VACCINE EXHIBITS POTEN...
EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous DEFENCE’S ACCUTOX ANTI-CANCER ARM-002 VACCINE EXHIBITS POTENT ANTIGEN PRESENTATION 23.04.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Vancouver, BC, Canada, April 23rd, 2024 - Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce that its second-generation ARMTM anti-cancer vaccine using ...
EQS-News: Screening completed: Berlin Cures achieves key milestone in ...
Issuer: Berlin Cures Holding AG / Key word(s): Miscellaneous Screening completed: Berlin Cures achieves key milestone in BC 007 Phase II Trial for treatment of Long COVID 23.04.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Berlin, Germany, 23 April 2024 – Berlin Cures, a pioneering clinical-stage biotechnology company, today announced the successful completion of patient screening for its pan-European Phase II trial of BC 007 (Rovunaptabin), a novel therapeutic candidate for the treatment of Long COVID. The study has now recr...
EQS-News: ekrutierung abgeschlossen: Berlin Cures erreicht wichtigen M...
Emittent / Herausgeber: Berlin Cures Holding AG / Schlagwort(e): Sonstiges ekrutierung abgeschlossen: Berlin Cures erreicht wichtigen Meilenstein in der Phase-II-Studie mit BC 007 zur Behandlung von Long COVID 23.04.2024 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Berlin, 23. April 2024 – Berlin Cures, ein Biotechnologieunternehmen in der klinischen Phase, hat heute den erfolgreichen Abschluss der Patientenrekrutierung für seine europaweite Phase-II-Studie mit BC 007 (Rovunaptabin) bekanntgegeben. BC 007 ist Berlin Cures‘ ...
United Airlines Holdings Inc: 1 director
A director at United Airlines Holdings Inc sold 30,000 shares at 50.843USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
- Oliver Metzger
- Stephan Wulf
Dermapharm Holding SE : Smooth integration of Arkopharma and declining...
>2023 net earnings also burdened by accounting-related charges - While the final sales and EBITDA figures confirmed the preliminary results released on 14 March, the net result for 2023 published for the first time obviously led to disappointment in the market. The significant increase in financial expenses (c +400% to € 73m), together with the lower operating result (-25%) due to the absence of the vaccine business, led to a significantly lower net result of € 60.5m ...
- Baptiste Lebacq
Saipem : Q1 2024 slightly lower than expectations
>EBIT 2% below expectations - Q1 2024 sales came in 18% higher y-o-y at € 3.05bn (in line with the FactSet consensus at € 3.06bn). EBITDA came to € 268m, or a margin of 8.8% (below consensus of € 272m), driven by offshore businesses (€ 180m from asset-based services, € 80m for offshore drilling and € 8m for energy carriers). The energy carriers division continues to be undermined by challenging contracts. All told, this division’s EBITDA margin came to 0.7%, an...
- ABGSC Construct. & Real Estate Research
- Bengt Jonassen
- Njål Kleiven
- ABGSC Construct. & Real Estate Research
- Fredrik Stensved
- Markus Henriksson
- Viktor Stenlöf
Arco Vara AS will hold an investor webinar to introduce the results fo...
Arco Vara AS will hold an investor webinar to introduce the results for the Q1 2024 Arco Vara invites all interested parties to join its investor webinar, scheduled on 25 April 2024 at 10 am (EET). The webinar will be held in Estonian. The webinar will be hosted by the CEO of Arco Vara Miko-Ove Niinemäe, who presents the unaudited financial results of the Q1 2024. The webinar takes place at the link: The webinar will be recorded and remains public on the company's website. Tiina Malm CFO Arco Vara AS
Innofactor Oyj:n osavuosikatsaus 1.1.–31.3.2024 (IFRS)
Innofactor Oyj:n osavuosikatsaus 1.1.–31.3.2024 (IFRS) Innofactor Oyj:n osavuosikatsaus 23.4.2024 klo 9.00 Innofactor kasvatti liikevaihtoaan jatkuneesta haastavasta markkinatilanteesta huolimatta vuoden 2024 ensimmäisellä neljänneksellä Tammi–maaliskuu 2024 lyhyesti: Liikevaihto oli noin 21,2 miljoonaa euroa (2023: 20,2), jossa kasvua 4,8 % Käyttökate oli noin 2,6 miljoonaa euroa (2023: 2,5), jossa kasvua 4,6 % Liikevoitto oli 1,8 miljoonaa euroa (2023: 1,7), jossa kasvua 7,3 % Tilauskanta oli katsauskauden lopussa 68,8 miljoonaa euroa (2023: 76,3), jossa laskua 9,8 % ...
Falcon Oil & Gas Ltd - Binding Term Sheet for Gas Sales Agreement to s...
Falcon Oil & Gas Ltd - Binding Term Sheet for Gas Sales Agreement to supply pilot gas to the Northern Territory Government Falcon Oil & Gas Ltd.(“Falcon”) Binding Term Sheet for Gas Sales Agreement to supply pilot gas to the Northern Territory Government 23 April 2024 - Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) is pleased to announce that the Beetaloo Joint venture (BJV) has signed a Binding Agreement for a long-term Gas Sales Agreement (GSA) to supply the Northern Territory Government (Buyer) with 14.6 PJ (13.8 BCF) per annum from the proposed Shenandoah South Pilot Project for an...
Legrand poursuit ses investissements dans les segments porteurs
LIMOGES, France--(BUSINESS WIRE)-- Regulatory News: Legrand (Paris:LR) poursuit activement sa stratégie de développement avec l’annonce de deux acquisitions dans les domaines porteurs de l’assistance à l’autonomie et la santé ainsi que dans les datacenters, venant renforcer les positions de leadership du Groupe dans ses segments à plus forte croissance. Enovation est le leader néerlandais des logiciels de santé dans le marché de la santé connectée et de l’assistance à l’autonomie. Spécialisées en B to B, les solutions d’Enovation intègrent notamment des offres logicielles pour la télésur...
Atari Revives Infogrames as a Publishing Label
Atari Revives Infogrames as a Publishing Label New label launches with the purchase of Totally Reliable Delivery Service from tinyBuild LLC NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- — one of the world's most iconic consumer brands and interactive entertainment producers — announced today it has established a new publishing label under the Infogrames brand. In launching the new label, Atari is reviving a legacy brand known for game development and global distribution from the early 1980s to the early 2000s. “For decades, Infogrames built a reputation as a publisher and developer of ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.